Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Anadin (Ibuprofen)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Anadin Ibuprofen 200mg tablets
1001010J0CJAAAD
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin Joint Pain 200mg tablets
1001010J0CJADAD
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin LiquiFast 200mg effervescent tablets
1001010J0CJAEBP
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin LiquiFast 400mg capsules
1001010J0CJACAU
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin Period Pain Relief 200mg capsules
1001010J0CJAFAA
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin Ultra 200mg capsules
1001010J0CJABAA
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.